ArticleBlood2026
Arterial iron regulates vasodilation during anemia via endothelial holo-α-globin.
Article in Blood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endothelial nitric oxide signaling in cellular and systemic metabolism.Redox biology · 2026Review
Corrections and comments
- Commented on by
- Update of
Authors and funding
15 authors.
Funding
Abstract
abstractIron deficiency is a highly prevalent nutrient deficiency and the most common cause of anemia. Although iron deficiency exacerbates cardiovascular disease, the direct impact of iron deficiency on the vasculature remains unstudied. We assessed iron levels across the vascular endothelium in mouse and human endothelial cells and found that resistance artery endothelial cells have the lowest iron stores, suggesting they may be especially affected by iron deficiency. Anemia has previously been shown to increase arterial nitric oxide (NO) signaling in patients, and we have previously shown endothelial α-globin scavenges NO in the resistance artery endothelium. We hypothesized that iron regulates vascular function through regulation of endothelial α-globin. To test this, we used a mouse model of iron deficiency anemia (IDA). In female mice, IDA increased NO signaling, which was rescued to control levels by repletion of vascular iron with iron dextran. Despite being similarly anemic and having a similar reduction in α-globin protein, there were no changes in NO signaling across groups in male mice. We further measured whether α-globin was in its heme-bound (holo-α-globin) or heme-free (apo-α-globin) state and found males did not fully lose its functional, heme-bound α-globin. Using endothelial-specific α-globin knockout mice, we show loss of endothelial α-globin is necessary for increased NO signaling in IDA and for the rescue of NO signaling by iron dextran in female mice. Altogether, the data presented here demonstrate iron is a determinant of endothelial identity and modulates endothelial NO signaling through the regulation of α-globin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.